April 23, 2003 - Endocardial Solutions Reports First Quarter Earnings Results; Record Number of EnSite cases; Cumulative EnSite System Upgrades Exceed 130

April 22, 2003<*dv_0*> - Endocardial Solutions Announces FDA approval of EnSite NavX™

April 21, 2003 - Endocardial Solutions Elects Richard J. Nigon and Jean-Paul (J.P.) Peltier as Directors

January 28, 2003 - Endocardial Solutions Releases Fourth Quarter and Year-End Earnings Results

January 3, 2003 - Endocardial Solutions Sells $8.5 Million in Common Stock

October 21, 2002 - Endocardial Solutions Reports Third Quarter Earnings Results

October 8, 2002 - Endocardial Solutions Announces First Digital Image Fusion (DIF) Procedure

October 1, 2002 - Endocardial Solutions to release third quarter earnings October 22, 2002

September 19th, 2002<*dv_5*> - Endocardial Solutions Announces the Resignation of Michael Dale

August 19th, 2002 - J. Robert Paulson, Jr. Joins Endocardial Solutions as Chief Financial Officer

August 14th, 2002 - Endocardial Solutions announces first successful human NAVEX procedure

July 22nd, 2002 - Endocardial Solutions reports second quarter 2002 earnings results

April 1st, 2002 - Endocardial Solutions to release first quarter earnings results April 23rd, 2002

February 27th, 2002 - Endocardial Solutions Sells $10 Million in Common Stock

January 23rd, 2002 - Endocardial Solutions Reports Fourth Quarter and 2001 Earnings Results: Sales up 58% over Q4'00 and Up 57% for Year; EnSite Catheter Sales up 87%

January 15th, 2002 - Endocardial Solutions names Mark Wagner Director

October 30th, 2001 - Endocardial Solutions Installs 200th System

October 22nd, 2001<*dv_3*> - Endocardial Solutions Reports Third Quarter Earnings Results: Sales up 88%, EnSite Catheter Revenues Up 101% Over Q3'00

October 2nd, 2001<*dv_2*> - Endocardial Solutions Announces FDA Clearance of Precision™ Software

July 25th, 2001 - Endocardial Solutions Signs Distributor Agreement with Nihon Kohden for Japanese Market.

July 18th, 2001<*dv_6*> - Endocardial Solutions Reports Second Quarter 2001 Earnings Results.

March 22nd, 2001 - Endocardial Solutions Sells Approximately $7.3 Million in Common Stock and Repays Loan to Medtronic.

January 29th, 2001 - Endocardial Solutions Receives FDA Approval to Begin Left Atrial Clinical Trial.

January 22nd, 2001<*dv_1*> - Endocardial Solutions Announces Fourth Quarter and 2000 Earnings Results.